APO RESEARCH · REPORT
Drug Abuse Treatment
Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
Product & engineering
Understand the product.
Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
Selected research
Industry Growth & Trends
Global Drug Abuse Treatment Industry Growth and Trends Forecast to 2032
Market perspective
Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
According to APO Research, the global Drug Abuse Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Drug Abuse Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Drug Abuse Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drug Abuse Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drug Abuse Treatment.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Drug Abuse Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Drug Abuse Treatment Market by Company
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
PLIVA (Odyssey)
Drug Abuse Treatment Segment by Type
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Drug Abuse Treatment Segment by Application
Hospital & Clinics
Residential (non-hospital)
Drug Abuse Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Abuse Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Abuse Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Abuse Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Drug Abuse Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Opioid Addiction
- Tobacco/Nicotine Addiction
- Alcohol Dependence
Applications
- Hospital & Clinics
- Residential (non-hospital)
Companies covered
- Indivior
- Pfizer
- Alkermes
- Novartis
- Mylan
- Cipla
- Glenmark
- Dr. Reddy's Laboratories
- Teva Pharmaceutical
- PLIVA (Odyssey)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Drug Abuse Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Drug Abuse Treatment Market Size by Region (2021-2032)
- 1.4.1 Global Drug Abuse Treatment Market Size by Region (2021-2026)
- 1.4.2 Global Drug Abuse Treatment Market Size by Region (2027-2032)
- 1.5 Key Regions Drug Abuse Treatment Market Size (2021-2032)
- 1.5.1 North America Drug Abuse Treatment Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Drug Abuse Treatment Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Drug Abuse Treatment Market Size Growth Rate (2021-2032)
- 1.5.4 South America Drug Abuse Treatment Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Drug Abuse Treatment Market Size Growth Rate (2021-2032)
2 Drug Abuse Treatment Market by Type
- 2.1 Type Introduction
- 2.1.1 Opioid Addiction
- 2.1.2 Tobacco/Nicotine Addiction
- 2.1.3 Alcohol Dependence
- 2.2 Global Drug Abuse Treatment Market Size by Type
- 2.2.1 Global Drug Abuse Treatment Market Size Overview by Type (2021-2032)
- 2.2.2 Global Drug Abuse Treatment Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Drug Abuse Treatment Market Size Forecasted by Type (2027-2032)
- 2.3 Global Drug Abuse Treatment Market Size by Regions
- 2.3.1 North America Drug Abuse Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Drug Abuse Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Drug Abuse Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Drug Abuse Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Drug Abuse Treatment Market Size Breakdown by Type (2021-2026)
3 Drug Abuse Treatment Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital & Clinics
- 3.1.2 Residential (non-hospital)
- 3.2 Global Drug Abuse Treatment Market Size by Application
- 3.2.1 Global Drug Abuse Treatment Market Size Overview by Application (2021-2032)
- 3.2.2 Global Drug Abuse Treatment Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Drug Abuse Treatment Market Size Forecasted by Application (2027-2032)
- 3.3 Global Drug Abuse Treatment Market Size by Regions
- 3.3.1 North America Drug Abuse Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Drug Abuse Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Drug Abuse Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Drug Abuse Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Drug Abuse Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Drug Abuse Treatment Industry Trends
- 4.2 Drug Abuse Treatment Industry Drivers
- 4.3 Drug Abuse Treatment Industry Opportunities and Challenges
- 4.4 Drug Abuse Treatment Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Drug Abuse Treatment Revenue (2021-2026)
- 5.2 Global Drug Abuse Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Drug Abuse Treatment Key Company Headquarters & Area Served
- 5.4 Global Drug Abuse Treatment Company, Product Type & Application
- 5.5 Global Drug Abuse Treatment Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Drug Abuse Treatment Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Drug Abuse Treatment Players Market Share by Revenue in 2025
- 5.6.3 2025 Drug Abuse Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Indivior
- 6.1.1 Indivior Company Information
- 6.1.2 Indivior Business Overview
- 6.1.3 Indivior Drug Abuse Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Indivior Drug Abuse Treatment Product Portfolio
- 6.1.5 Indivior Recent Developments
- 6.2 Pfizer
- 6.2.1 Pfizer Company Information
- 6.2.2 Pfizer Business Overview
- 6.2.3 Pfizer Drug Abuse Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Pfizer Drug Abuse Treatment Product Portfolio
- 6.2.5 Pfizer Recent Developments
- 6.3 Alkermes
- 6.3.1 Alkermes Company Information
- 6.3.2 Alkermes Business Overview
- 6.3.3 Alkermes Drug Abuse Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Alkermes Drug Abuse Treatment Product Portfolio
- 6.3.5 Alkermes Recent Developments
- 6.4 Novartis
- 6.4.1 Novartis Company Information
- 6.4.2 Novartis Business Overview
- 6.4.3 Novartis Drug Abuse Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Novartis Drug Abuse Treatment Product Portfolio
- 6.4.5 Novartis Recent Developments
- 6.5 Mylan
- 6.5.1 Mylan Company Information
- 6.5.2 Mylan Business Overview
- 6.5.3 Mylan Drug Abuse Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Mylan Drug Abuse Treatment Product Portfolio
- 6.5.5 Mylan Recent Developments
- 6.6 Cipla
- 6.6.1 Cipla Company Information
- 6.6.2 Cipla Business Overview
- 6.6.3 Cipla Drug Abuse Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Cipla Drug Abuse Treatment Product Portfolio
- 6.6.5 Cipla Recent Developments
- 6.7 Glenmark
- 6.7.1 Glenmark Company Information
- 6.7.2 Glenmark Business Overview
- 6.7.3 Glenmark Drug Abuse Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Glenmark Drug Abuse Treatment Product Portfolio
- 6.7.5 Glenmark Recent Developments
- 6.8 Dr. Reddy's Laboratories
- 6.8.1 Dr. Reddy's Laboratories Company Information
- 6.8.2 Dr. Reddy's Laboratories Business Overview
- 6.8.3 Dr. Reddy's Laboratories Drug Abuse Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Dr. Reddy's Laboratories Drug Abuse Treatment Product Portfolio
- 6.8.5 Dr. Reddy's Laboratories Recent Developments
- 6.9 Teva Pharmaceutical
- 6.9.1 Teva Pharmaceutical Company Information
- 6.9.2 Teva Pharmaceutical Business Overview
- 6.9.3 Teva Pharmaceutical Drug Abuse Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Teva Pharmaceutical Drug Abuse Treatment Product Portfolio
- 6.9.5 Teva Pharmaceutical Recent Developments
- 6.10 PLIVA (Odyssey)
- 6.10.1 PLIVA (Odyssey) Company Information
- 6.10.2 PLIVA (Odyssey) Business Overview
- 6.10.3 PLIVA (Odyssey) Drug Abuse Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 PLIVA (Odyssey) Drug Abuse Treatment Product Portfolio
- 6.10.5 PLIVA (Odyssey) Recent Developments
7 North America
- 7.1 North America Drug Abuse Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Drug Abuse Treatment Market Size by Country (2021-2026)
- 7.3 North America Drug Abuse Treatment Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Drug Abuse Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Drug Abuse Treatment Market Size by Country (2021-2026)
- 8.3 Europe Drug Abuse Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Drug Abuse Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Drug Abuse Treatment Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Drug Abuse Treatment Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Drug Abuse Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Drug Abuse Treatment Market Size by Country (2021-2026)
- 10.3 South America Drug Abuse Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Drug Abuse Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Drug Abuse Treatment Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Drug Abuse Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst